Bristol Expands R&D In India Through Biocon Deal

Bristol-Myers Squibb is expanding its research and development presence in India through a deal with Bangalore-based Biocon on discovery research work involving medicinal chemistry, biology and drug metabolism, the firms announced March 14

More from Archive

More from Scrip